Logo of gutGutView this articleSubmit a manuscriptReceive email alertsContact usBMJ
Gut. 1999 Oct; 45(4): 588–592.
PMCID: PMC1727686

The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer


AIMS—To determine the harm that ensues from faecal occult blood (FOB) screening for colorectal cancer.
METHODS—150 251 people were randomly allocated either to receive biennial Haemoccult FOB tests (n =75 253) or not to be contacted (n=74 998). Study group patients returning positive tests were offered colonic investigation; 1774 underwent complete investigation of the colon.
RESULTS—There was no significant difference in the stage at presentation of interval versus control group cancers. Survival in the interval cancer group was significantly prolonged compared with the control group. Sensitivity for colonoscopy or flexible sigmoidoscopy and double contrast barium enema (DCBE) was 96.7%. There were no complications of DCBE but seven (0.5%) complications of colonoscopy, of which six required surgical intervention. There were no colonoscopy related deaths. No patients without colorectal cancer died within 30 days of colonic investigation. Five patients died within 30 days of surgery for screen detected colorectal neoplasia and a further two died without having surgery. Six patients died after 30 days but within two years of surgery for screen detected benign adenomas or stage A cancers; in all cases the cause of death was not related to colorectal cancer.
CONCLUSIONS—There was investigation related morbidity but no mortality and little to support overdiagnosis bias. The group returning falsely negative tests had a better outcome compared with the whole control group. There is a negative side to any screening programme but mortality reduction in this and other trials suggests that a national programme of colorectal cancer screening should be given consideration.

Keywords: screening; colorectal cancer; faecal occult blood test; Haemoccult; colonoscopy

Full Text

The Full Text of this article is available as a PDF (78K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Stower MJ, Hardcastle JD. The results of 1115 patients with colorectal cancer treated over an 8-year period in a single hospital. Eur J Surg Oncol. 1985 Jun;11(2):119–123. [PubMed]
  • Umpleby HC, Bristol JB, Rainey JB, Williamson RC. Survival of 727 patients with single carcinomas of the large bowel. Dis Colon Rectum. 1984 Dec;27(12):803–810. [PubMed]
  • Mella J, Biffin A, Radcliffe AG, Stamatakis JD, Steele RJ. Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg. 1997 Dec;84(12):1731–1736. [PubMed]
  • Saito H, Soma Y, Koeda J, Wada T, Kawaguchi H, Sobue T, Aisawa T, Yoshida Y. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer. 1995 May 16;61(4):465–469. [PubMed]
  • Wahrendorf J, Robra BP, Wiebelt H, Oberhausen R, Weiland M, Dhom G. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev. 1993 May;2(3):221–227. [PubMed]
  • Lazovich D, Weiss NS, Stevens NG, White E, McKnight B, Wagner EH. A case-control study to evaluate efficacy of screening for faecal occult blood. J Med Screen. 1995;2(2):84–89. [PubMed]
  • Zappa M, Castiglione G, Grazzini G, Falini P, Giorgi D, Paci E, Ciatto S. Effect of faecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy. Int J Cancer. 1997 Oct 9;73(2):208–210. [PubMed]
  • Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13;328(19):1365–1371. [PubMed]
  • Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996 Nov 30;348(9040):1472–1477. [PubMed]
  • Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996 Nov 30;348(9040):1467–1471. [PubMed]
  • Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ. 1998 Aug 29;317(7158):559–565. [PMC free article] [PubMed]
  • Whynes DK, Walker AR, Chamberlain JO, Hardcastle JD. Screening and the costs of treating colorectal cancer. Br J Cancer. 1993 Nov;68(5):965–968. [PMC free article] [PubMed]
  • Marteau TM. Psychological costs of screening. BMJ. 1989 Aug 26;299(6698):527–527. [PMC free article] [PubMed]
  • Ahlquist DA. Fecal occult blood testing for colorectal cancer. Can we afford to do this? Gastroenterol Clin North Am. 1997 Mar;26(1):41–55. [PubMed]
  • Turnbull RB, Jr, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg. 1967 Sep;166(3):420–427. [PMC free article] [PubMed]
  • Whynes DK, Neilson AR, Walker AR, Hardcastle JD. Faecal occult blood screening for colorectal cancer: is it cost-effective? Health Econ. 1998 Feb;7(1):21–29. [PubMed]
  • Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology. 1997 Jan;112(1):17–23. [PubMed]
  • Macrae FA, Tan KG, Williams CB. Towards safer colonoscopy: a report on the complications of 5000 diagnostic or therapeutic colonoscopies. Gut. 1983 May;24(5):376–383. [PMC free article] [PubMed]
  • Hara AK, Johnson CD, Reed JE, Ahlquist DA, Nelson H, Ehman RL, McCollough CH, Ilstrup DM. Detection of colorectal polyps by computed tomographic colography: feasibility of a novel technique. Gastroenterology. 1996 Jan;110(1):284–290. [PubMed]
  • Rembold CM. Number needed to screen: development of a statistic for disease screening. BMJ. 1998 Aug 1;317(7154):307–312. [PMC free article] [PubMed]

Articles from Gut are provided here courtesy of BMJ Group


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    PubChem Compound links
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...